Skip to main content
. 2010 May 20;37(3):155–159. doi: 10.1159/000313993

Table 1.

Prevalence of selected diagnoses in Germany 2007, 2030 und 2050a

Diagnosis Absolute numbers (rounded)
Relative numbers (per 100,000)
2007b 2030 2050 2007 2030 2050
Age-dependent macula degeneration [10]c 875,000 1,300,000 (+46%) 1,800,000 (+102%) 1,065 1,660 (+56%) 2,574 (+142%)
Osteoporosis [11]c 8,300,000 10,200,000 (+23%) 10,400,000 (+26%) 10,068 13,209 (+31%) 15,131 (+50%)
Arthritis [12]c 13,600,000 15,600,000 (+15%) 14,900,000 (+9%) 16,554 20,191 (+22%) 21,606 (+31%)
Diabetes mellitus [13,14]c 4,100,000−6,400,000 4,900,000−7,800,000 (+22%) 5,800,000−7,800,000 (+20–22%) 4,993–7,730 6,497−10,056 (+30%) 7,185−11,287 (+44–46%)
Hypertension [15]c 34,800,000 37,900,000 (+9%) 35,500,000 (+2%) 42,367 49,035 (+16%) 51,591 (+22%)
Chronic obstructive lung disease [16]c 6,400,000 7,900,000 (+23%) 7,900,000 (+23%) 7,829 10,259 (+31%) 11,533 (+47%)
Dialysis [17]c 72,000 84,800 (+18%) 85,300 (+18%) 88 110 (+25%) 124 (+41%)
Dementia [18]c 31,100,000 1,600,000 (+51%) 2,200,000 (+104%) 1,300 2,092 (+61%) 3,175 (+144%)
a

Total numbers, crude rates per 100,000 inhabitants and percentage change compared to 2007 (in parentheses).

b

Prevalence is projected to the German population in 2007.

c

Literature referred to the prevalence rate that is used for the projection.